노인 영양용 단백질 가수분해물 시장 기회, 성장 촉진요인, 업계 동향 분석 및 예측(2026-2035년)

The Global Geriatric Nutrition Protein Hydrolysates Market was valued at USD 444 million in 2025 and is estimated to grow at a CAGR of 7.6% to reach USD 921 million by 2035.

Protein hydrolysates are produced by converting proteins into shorter peptide chains and free amino acids through enzymatic, acid, or alkaline processing. Their value in geriatric nutrition extends beyond delivering protein because their structure can support faster absorption while reducing digestive demands. These characteristics make hydrolyzed protein particularly relevant to nutritional products developed for older adults experiencing gastrointestinal impairment, malabsorption, reduced appetite, or an elevated risk of muscle loss. As aging populations increase and nutritional requirements become more specialized, demand is shifting toward formulations that can provide effective protein support with improved tolerance and absorption. Manufacturers are consequently focusing on hydrolysate-based nutritional solutions that address the physiological challenges associated with aging. The growing emphasis on maintaining nutritional status and supporting muscle health is also creating opportunities for specialized protein ingredients across clinical and home-based nutrition settings.

Animal-based protein hydrolysates segment accounted for USD 315 million in 2025 and is forecast to grow at a CAGR of 6.8% through 2035. Milk and casein hydrolysates represent the largest category within this segment, while whey protein hydrolysates rank next. The established nutritional profiles and functional characteristics of animal-derived proteins continue to support their use in specialized geriatric nutrition formulations. Manufacturers can further process these protein sources into hydrolysates to improve their suitability for products designed around specific digestive and nutritional requirements.

Clinical nutrition segment held USD 200 million in 2025. Hospital nutrition programs and tube-feeding products represent the dominant areas of use, as gastrointestinal impairment and malabsorption can increase the need for hydrolyzed protein formulations. ESPEN guidance connects adequate protein support with nutritional care for older adults, providing additional support for formulas designed to promote tolerance and efficient absorption. Demand for clinical nutrition products is therefore being reinforced by the need for specialized nutritional solutions that can address the dietary challenges associated with aging and compromised digestive function.

North America Geriatric Nutrition Protein Hydrolysates Market captured USD 146 million in 2025 and is forecast to grow at a CAGR of 6.6% through 2035. The United States serves as the region's primary market, supported by hospital-based nutrition support teams, established homecare enteral nutrition systems, and broad access to direct-to-consumer supplements. These multiple distribution channels allow manufacturers to reach older consumers across institutional and home-based care environments. Canada contributes additional demand from institutional clinical nutrition, although the region's relatively high market penetration is expected to moderate its growth rate compared with less-developed markets.

Major companies participating in the global geriatric nutrition protein hydrolysates market include Fonterra, Nestle Health Science, Arla Foods Ingredients, Royal FrieslandCampina, and Kerry Group. Companies in the global geriatric nutrition protein hydrolysates market are strengthening their market foothold through product innovation, portfolio expansion, clinical nutrition partnerships, and improvements in formulation technology. Leading participants are developing hydrolysates with targeted peptide profiles to support digestibility, absorption, and nutritional tolerance among older consumers. Companies are also expanding their protein portfolios across milk, casein, and whey sources to address diverse formulation requirements. Partnerships with healthcare providers, nutrition specialists, and institutional care channels can help manufacturers expand product adoption and strengthen market access. Investments in research and development enable suppliers to improve formulation performance while responding to evolving geriatric nutrition needs. Companies are also increasing distribution through homecare and consumer channels to reach broader customer groups. By combining specialized product development, quality improvements, expanded distribution networks, and stronger relationships across clinical nutrition channels, market participants are positioning themselves to capture growing demand for protein hydrolysate solutions in geriatric care.

Table of Contents

Chapter 1. Methodology

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2. Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional
  • 2.2.2 Source
  • 2.2.3 Distribution Channel
  • 2.2.4 Application
• 2.3 TAM Analysis, 2026-2035
• 2.4 CXO perspectives: Strategic imperatives
  • 2.4.1 Executive decision points
  • 2.4.2 Critical success factors
• 2.5 Future Outlook and Strategic Recommendations

Chapter 3. Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier Landscape
  • 3.1.2 Profit Margin
  • 3.1.3 Value addition at each stage
  • 3.1.4 Factor affecting the value chain
  • 3.1.5 Disruptions
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
  • 3.2.2 Industry pitfalls and challenges
  • 3.2.3 Market opportunities
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East & Africa
• 3.5 Porter’s analysis
• 3.6 PESTEL analysis
• 3.7 Price trends
  • 3.7.1 By region
  • 3.7.2 By product
• 3.8 Future market trends
• 3.9 Technology and Innovation landscape
  • 3.9.1 Current technological trends
  • 3.9.2 Emerging technologies
• 3.10 Patent Landscape
• 3.11 Trade statistics (Note: the trade statistics will be provided for key countries only)
  • 3.11.1 Major importing countries
  • 3.11.2 Major exporting countries
• 3.12 Sustainability and Environmental Aspects
  • 3.12.1 Sustainable Practices
  • 3.12.2 Waste Reduction Strategies
  • 3.12.3 Energy Efficiency in Production
  • 3.12.4 Eco-friendly Initiatives
• 3.13 Carbon Footprint Considerations

Chapter 4. Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 By region
    • 4.2.1.1 North America
    • 4.2.1.2 Europe
    • 4.2.1.3 Asia Pacific
    • 4.2.1.4 LATAM
    • 4.2.1.5 MEA
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New Product Launches
  • 4.6.4 Expansion Plans

Chapter 5. Market Estimates and Forecast, By Source, 2022 - 2035 (USD Million, Kilo Tons)

• 5.1 Key trends
• 5.2 Animal-based
  • 5.2.1 Milk protein hydrolysates (casein, whey)
  • 5.2.2 Egg protein hydrolysates
  • 5.2.3 Meat protein hydrolysates
  • 5.2.4 Fish protein hydrolysates
• 5.3 Plant-based
  • 5.3.1 Soy protein hydrolysates
  • 5.3.2 Pea protein hydrolysates
  • 5.3.3 Rice protein hydrolysates
  • 5.3.4 Other plant sources (e.g., wheat, corn)

Chapter 6. Market Estimates and Forecast, By Distribution Channel, 2022 - 2035 (USD Million, Kilo Tons)

• 6.1 Key trends
• 6.2 Hospital pharmacies
• 6.3 Retail pharmacies
• 6.4 Online stores
• 6.5 Specialty stores

Chapter 7. Market Estimates and Forecast, By Application, 2022 - 2035 (USD Million, Kilo Tons)

• 7.1 Key trends
• 7.2 Clinical nutrition
  • 7.2.1 Hospital-based nutrition
  • 7.2.2 Tube feeding formulations
• 7.3 Functional foods & beverages
  • 7.3.1 Nutritional drinks
  • 7.3.2 Fortified foods
• 7.4 Dietary supplements
  • 7.4.1 Capsules
  • 7.4.2 Tablets
  • 7.4.3 Sachets
• 7.5 Others

Chapter 8. Market Estimates and Forecast, By Region, 2022 - 2035 (USD Million, Kilo Tons)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 India
  • 8.4.3 Japan
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East & Africa

Chapter 9. Company Profiles

• 9.1 Arla Foods Ingredients
• 9.2 Mead Johnson Nutrition
• 9.3 Merck KGaA
• 9.4 Fonterra Co-operative Group
• 9.5 Agropur Cooperative
• 9.6 Milk Specialties Global
• 9.7 Tatua Co-operative Dairy Company
• 9.8 Royal FrieslandCampina N.V.
• 9.9 Hilmar Cheese Company
• 9.10 Kerry Group
• 9.11 DuPont (Danisco)
• 9.12 Nestle Health Science
• 9.13 Rousselot
• 9.14 Gelita AG
• 9.15 Evonik Industries